Investigating Molecular Mechanisms of Qijia Rougan Prescription and Its Key Effect or Ingredients Against Hepatic Fibrosis Based on Macrophage M2 Polarization

WEN Li; FENG Quansheng; JIANG Cen; LI Baixue; WANG Dong; LI Jike; LI Xia; WAN Fei; ZHENG Yanfeng

doi:10.13422/j.cnki.syfjx.20251012

Your Location：

Home >

Browse articles >

Investigating Molecular Mechanisms of Qijia Rougan Prescription and Its Key Effect or Ingredients Against Hepatic Fibrosis Based on Macrophage M2 Polarization

Updated：2026-06-18

Previous|Next

- Investigating Molecular Mechanisms of Qijia Rougan Prescription and Its Key Effect or Ingredients Against Hepatic Fibrosis Based on Macrophage M2 Polarization
  Enhanced Publication
- “Qi Jia Rou Gan Fang inhibits M2 macrophage polarization and improves liver fibrosis. Its key effector components glycyrrhetinic acid and berberine can target JAK1 to regulate the JAK1/STAT6 signaling pathway, providing a basis for the development of new drugs for liver fibrosis.”
- WEN Li , FENG Quansheng , JIANG Cen , LI Baixue , WANG Dong , LI Jike , LI Xia , WAN Fei , ZHENG Yanfeng
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 14, Pages: 155-165(2026)
- Affiliations：
  1.College of Basic Medicine， Chengdu University of Traditional Chinese Medicine（TCM）， Chengdu 611137，China
  2.College of TCM， Chongqing Medical and Pharmaceutical College， Chongqing 401331，China
  3.Public Health Clinic Center of Chengdu，Chengdu 610061，China
- Author bio：
- Funds：
- DOI： 10.13422/j.cnki.syfjx.20251012
  CLC：
- Revised：2025-08-19 ，
  Accepted：24 August 2025 ，
- Accepted：
Scan QR Code
DOI：
DOI：

AI Introduction
Full Text(HTML)
Figs( 4 ) Tabs( 8 )
References
Publication Info
Metrics

212

Views

102

Downloads

0

CSCD

Alert me when the article has been cited

Submit

Tools

BibTeXDownload
EndnoteDownload
RefMan Download
NoteExpressDownload
NoteFirstDownload

Publicity Resources

Related Articles

Gantou Fumu Decoction Inhibits Hepatic Stellate Cell Activation by Regulating Nrf2/ARE Signaling Pathway

Predicting Hepatic Fibrosis Risk in Wilson's Disease： Development and Validation of Prognostic Model Integrating TCM Syndromes and Modern Biomarkers

Mechanism of Qinggan Jianpi Huoxue Prescription Against Hepatic Fibrosis via FoxO1 Mediated Regulation of Glycolytic Metabolic Reprogramming of Hepatic Stellate Cells

Guizhi Fulingwan Alleviate Hepatic Fibrosis by Modulating mtDNA/NLRP3/Caspase-1/GSDMD Signaling Pathway

Staged Treatment of Hepatic Fibrosis Based on Correlation Between "Collaterals and Vascular System" and Theory of "Hepatic Collateral Disease"

Related Author

HE Wangsheng

ZHU Yanping

LONG Shizhen

LI Mengmeng

YANG Wenming

WANG Han

WANG Meixia

DONG Ting

Related Institution

The First Affiliated Hospital of Anhui University of Chinese Medicine

Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine， Institute of Health and Medicine，Hefei Comprehensive National Science Center

Key Laboratory of Xin'an Medicine， Ministry of Education

Graduate School，Anhui University of Chinese Medicine

Shenzhen Hospital （Futian） of Guangzhou University of Chinese Medicine

Intro

Chat

Investigating Molecular Mechanisms of Qijia Rougan Prescription and Its Key Effect or Ingredients Against Hepatic Fibrosis Based on Macrophage M2 Polarization

DOI： 10.13422/j.cnki.syfjx.20251012

AI Introduction

Full Text(HTML)

Figs( 4 ) Tabs( 8 )

References

Publication Info

Metrics

摘要

Abstract

关键词

Keywords

references